{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:27:20Z","timestamp":1793600840566,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ophtha.2026.02.025","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:44:52Z","timestamp":1772095492000},"page":"895-902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ophthalmic Drug Shortages in the United States"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9396-8203","authenticated-orcid":false,"given":"Robert T.","family":"Eakins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1549-7805","authenticated-orcid":false,"given":"Lieu Nguyen","family":"Lowrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4023-1885","authenticated-orcid":false,"given":"Brian C.","family":"Stagg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4049-188X","authenticated-orcid":false,"given":"Adaora","family":"Okudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7847-6517","authenticated-orcid":false,"given":"Rachel","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marrisa","family":"Larochelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin R.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Pitha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ophtha.2026.02.025_bib1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.mayocp.2013.11.014","article-title":"Drug shortages: a complex health care crisis","volume":"89","author":"Fox","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ophtha.2026.02.025_bib2","series-title":"Impact of drug shortages on patients in the United States: a case study of three drugs: ASPE report","author":"Beleche","year":"2024"},{"issue":"10","key":"10.1016\/j.ophtha.2026.02.025_bib3","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1111\/bcp.15853","article-title":"Drug shortages. Part 2: trends, causes and solutions","volume":"89","author":"Aronson","year":"2023","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.ophtha.2026.02.025_bib4","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1111\/bcp.15842","article-title":"Drug shortages. Part 1. Definitions and harms","volume":"89","author":"Aronson","year":"2023","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.ophtha.2026.02.025_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.4246","article-title":"Drug shortages prior to and during the COVID-19 pandemic","volume":"7","author":"Callaway Kim","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.ophtha.2026.02.025_bib6","first-page":"783","article-title":"Effects on patient care caused by drug shortages: a survey","volume":"19","author":"McLaughlin","year":"2013","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.ophtha.2026.02.025_bib7","series-title":"Analysis of drug shortages, 2018-2023: data brief","author":"McGeeney","year":"2025"},{"key":"10.1016\/j.ophtha.2026.02.025_bib8","series-title":"Drug shortages: HHS should implement a mechanism to better coordinate its response","year":"2025"},{"key":"10.1016\/j.ophtha.2026.02.025_bib9","series-title":"American Hospital Association Costs of Caring Report","year":"2026"},{"issue":"1","key":"10.1016\/j.ophtha.2026.02.025_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jtos.2011.12.002","article-title":"Drug shortages","volume":"10","author":"Novack","year":"2012","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ophtha.2026.02.025_bib11","first-page":"38","article-title":"The Akorn bankruptcy","author":"Williams","year":"2023","journal-title":"EyeNet"},{"issue":"21","key":"10.1016\/j.ophtha.2026.02.025_bib12","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.2146\/ajhp180441","article-title":"ASHP guidelines on managing drug product shortages","volume":"75","author":"Fox","year":"2018","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ophtha.2026.02.025_bib13","series-title":"Certain Factors Are Strongly Associated with This Persistent Public Health Challenge","article-title":"Drug Shortages","year":"2016"},{"key":"10.1016\/j.ophtha.2026.02.025_bib14","series-title":"Office United States Government Accountability Office","article-title":"Drug Shortages: Better Management of the Quota Process for Controlled Substances Needed; Coordination between DEA and FDA Should Be Improved","year":"2015"},{"key":"10.1016\/j.ophtha.2026.02.025_bib15","series-title":"Public Health Threat Continues, Despite Efforts to Help Ensure Product Availability","author":"Drug Shortages","year":"2014"},{"key":"10.1016\/j.ophtha.2026.02.025_bib16","series-title":"Drug Shortages FDA\u2019s Ability to Respond Should Be Strengthened","year":"2011"},{"key":"10.1016\/j.ophtha.2026.02.025_bib17","series-title":"AHFS Drug Information 2025","year":"2025"},{"key":"10.1016\/j.ophtha.2026.02.025_bib18","series-title":"Basic and Clinical Science Course, 2024\u20132025 Edition","article-title":"American Academy of Ophthalmology","year":"2024"},{"key":"10.1016\/j.ophtha.2026.02.025_bib22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jcrc.2017.06.005","article-title":"U.S. drug shortages for medications used in adult critical care (2001-2016)","volume":"41","author":"Mazer-Amirshahi","year":"2017","journal-title":"J Crit Care"},{"key":"10.1016\/j.ophtha.2026.02.025_bib23","first-page":"1","article-title":"Leveraging a Bayesian network approach to model and analyze supplier vulnerability to severe weather risk: a case study of the U.S. pharmaceutical supply chain following Hurricane Maria","volume":"49","author":"Jeanne-Marie","year":"2020","journal-title":"Int J Disaster Risk Reduct"},{"issue":"17","key":"10.1016\/j.ophtha.2026.02.025_bib24","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1093\/ajhp\/zxae150","article-title":"The empty code cart: drug shortages over time","volume":"81","author":"Gentile","year":"2024","journal-title":"Am J Health Syst Pharm"},{"issue":"22","key":"10.1016\/j.ophtha.2026.02.025_bib25","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1093\/ajhp\/zxac210","article-title":"US drug shortages compared to the World Health Organization\u2019s model list of essential medicines for children: a cross-sectional study","volume":"79","author":"Patel","year":"2022","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ophtha.2026.02.025_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ajem.2021.12.064","article-title":"Nearly all thirty most frequently used emergency department drugs experienced shortages from 2006-2019","volume":"53","author":"Lin","year":"2022","journal-title":"Am J Emerg Med"},{"issue":"11","key":"10.1016\/j.ophtha.2026.02.025_bib27","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jval.2018.04.1826","article-title":"Predictors of drug shortages and association with generic drug prices: a retrospective cohort study","volume":"21","author":"Dave","year":"2018","journal-title":"Value Health"},{"key":"10.1016\/j.ophtha.2026.02.025_bib28","article-title":"Drug Shortages: Frequently Asked Questions","year":"2024","journal-title":"United States Food and Drug Administration"},{"key":"10.1016\/j.ophtha.2026.02.025_bib29","article-title":"Federal Food, Drug, and Cosmetic Act \u00a7 506C, 21 USC \u00a7 356c (2012). Section 506C of the Federal Food, Drug, and Cosmetic Act","volume":"21","year":"2012","journal-title":"United States Code"},{"key":"10.1016\/j.ophtha.2026.02.025_bib30","series-title":"Food and Drug Administration Safety and Innovation Act. Pub L No. 112-144, 126 Stat 993 (2012), amending Federal Food, Drug, and Cosmetic Act \u00a7506C, 21 USC \u00a7356c.Innovation Act (FDASIA)","year":"2012"},{"key":"10.1016\/j.ophtha.2026.02.025_bib31","series-title":"Coronavirus Aid, Relief, and Economic Security (CARES) Act, 2020, U.S. Congress.Pub L No. 116-136, 134 Stat 281","year":"2020"},{"key":"10.1016\/j.ophtha.2026.02.025_bib32","series-title":"Eye on Advocacy","article-title":"Academy presses FDA on policy to address drug shortages","year":"2023"},{"key":"10.1016\/j.ophtha.2026.02.025_bib33","author":"Williams"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642026001259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642026001259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:36:46Z","timestamp":1793597806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642026001259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0161642026001259"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2026.02.025","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ophthalmic Drug Shortages in the United States","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2026.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}